Evaluation of tissue PCA3 expression in prostate cancer by RNA in situ hybridization- a correlative study with urine PCA3 and TMPRSS2-ERG

被引：26
|
作者：
Warrick, Joshua I. [1 ]
Tomlins, Scott A. [1 ,2 ,3 ,4 ]
Carskadon, Shannon L. [1 ,2 ]
Young, Allison M. [1 ]
Siddiqui, Javed [1 ,2 ]
Wei, John T. [4 ]
Chinnaiyan, Arul M. [1 ,2 ,3 ,4 ,5 ]
Kunju, Lakshmi P. [1 ,2 ,3 ]
Palanisamy, Nallasivam [1 ,2 ,3 ]
机构：
[1] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48104 USA
[2] Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI USA
[3] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI USA
[4] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI USA
[5] Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA
来源：
MODERN PATHOLOGY | 2014年 / 27卷 / 04期
基金：
美国国家卫生研究院;
关键词：
PCA3; prostate cancer; RNA in situ hybridization; ANTIBODY-BASED DETECTION; ETS GENE FUSIONS; INTRAEPITHELIAL NEOPLASIA; ANTIGEN; REARRANGEMENT STATUS; TMPRSS2/ERG; CARCINOMA; DD3;
D O I：
10.1038/modpathol.2013.169
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
PCA3 is a prostate-specific non-coding RNA, with utility as a urine-based early detection biomarker. Here, we report the evaluation of tissue PCA3 expression by RNA in situ hybridization in a cohort of 41 mapped prostatectomy specimens. We compared tissue PCA3 expression with tissue level ERG expression and matched pre-prostatectomy urine PCA3 and TMPRSS2-ERG levels. Across 136 slides containing 138 foci of prostate cancer, PCA3 was expressed in 55% of cancer foci and 71% of high-grade prostatic intraepithelial neoplasia foci. Overall, the specificity of tissue PCA3 was >90% for prostate cancer and high-grade prostatic intraepithelial neoplasia combined. Tissue PCA3 cancer expression was not significantly associated with urine PCA3 expression. PCA3 and ERG positivity in cancer foci was positively associated (P<0.01). We report the first comprehensive assessment of PCA3 expression in prostatectomy specimens, and find limited correlation between tissue PCA3 and matched urine in prostate cancer.
引用
收藏
页码：609 / 620
页数：12
相关论文
共 50 条
  • [41] Expression of PCA3 and PSA genes as a biomarker for differential diagnosis of nodular hyperplasia and prostate cancer
    Fonseca Coelho, F.
    Loll Guimaraes, F.
    Ribeiro Cabral, W. L.
    Oliveira Salles, P. G.
    Cueva Mateo, E.
    Mendes Nogueira e Nogueira, L.
    Corradi Fonseca, C. E.
    Braga Gomes, K.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (04) : 13519 - 13531
  • [42] Follow-up of men with an elevated PCA3 score and a negative biopsy: does an elevated PCA3 score indeed predict the presence of prostate cancer?
    Remzi, Mesut
    Haese, Alexander
    van Poppel, Hein
    de la Taille, Alexandre
    Stenzl, Arnulf
    Hennenlotter, Joerg
    Marberger, Michael
    BJU INTERNATIONAL, 2010, 106 (08) : 1138 - 1142
  • [43] Use of PCA3 in detecting prostate cancer in initial and repeat prostate biopsy patients
    Goode, Roland R.
    Marshall, Susan J.
    Duff, Michael
    Chevli, Eric
    Chevli, K. Kent
    PROSTATE, 2013, 73 (01) : 48 - 53
  • [44] Differential Display Code 3 (DD3/PCA3) in Prostate Cancer Diagnosis
    Klecka, J.
    Holubec, L.
    Pesta, M.
    Topolcan, O.
    Hora, M.
    Eret, V.
    Finek, J.
    Chottova-Dvorakova, M.
    Babjuk, M.
    Novak, K.
    Stolz, J.
    ANTICANCER RESEARCH, 2010, 30 (02) : 665 - 670
  • [45] Clinical Use of PCA3 and TMPRSS2:ERG Urinary Biomarkers in African-American Men Undergoing Prostate Biopsy
    Feibus, Allison H.
    Sartor, Oliver
    Moparty, Krishnarao
    Chagin, Kevin
    Kattan, Michael W.
    Ledet, Elisa
    Levy, Justin
    Lee, Benjamin
    Thomas, Raju
    Silberstein, Jonathan L.
    JOURNAL OF UROLOGY, 2016, 196 (04) : 1053 - 1059
  • [46] Performance of Prostate Cancer Antigen 3 (PCA3) and Prostate-Specific Antigen in Prescreened Men: Reproducibility and Detection Characteristics for Prostate Cancer Patients with High PCA3 Scores (≥100)
    Roobol, Monique J.
    Schroder, Fritz H.
    van Leenders, Geert L. J. H.
    Hessels, Daphne
    van den Bergh, Roderick C. N.
    Wolters, Tineke
    van Leeuwen, Pim J.
    EUROPEAN UROLOGY, 2010, 58 (06) : 893 - 899
  • [47] A review on the role of PCA3 lncRNA in carcinogenesis with an especial focus on prostate cancer
    Ghafouri-Fard, Soudeh
    Khoshbakht, Tayyebeh
    Hussen, Bashdar Mahmud
    Baniahmad, Aria
    Taheri, Mohammad
    Rashnoo, Fariborz
    PATHOLOGY RESEARCH AND PRACTICE, 2022, 231
  • [48] Biopsy and Radical Prostatectomy Pathological Patterns Influence Prostate Cancer Gene 3 (PCA3) Score
    De Luca, Stefano
    Passera, Roberto
    Bollito, Enrico
    Milillo, Angela
    Scarpa, Roberto Mario
    Papotti, Mauro
    Coda, Renato
    Randone, Donato Franco
    ANTICANCER RESEARCH, 2013, 33 (10) : 4657 - 4662
  • [49] What information can a PCA3 urine test provide in the diagnosis and treatment of prostate cancer?
    Durand, X.
    Xylinas, E.
    Ploussard, G.
    de la Taille, A.
    JOURNAL OF MENS HEALTH, 2011, 8 (03) : 164 - 169
  • [50] The performance and limitations of PCA3, TMPRSS2:ERG, HOXC6 and DLX1 urinary markers combined in the improvement of prostate cancer diagnostics
    Mytsyk, Yulian
    Nakonechnyi, Yosyf
    Dosenko, Victor
    Kowal, Pawel
    Pietrus, Michal
    Gazdikova, Katarina
    Labudova, Monika
    Caprnda, Martin
    Prosecky, Robert
    Dragasek, Jozef
    Kruzliak, Peter
    Dats, Roman
    CLINICAL BIOCHEMISTRY, 2023, 116 : 120 - 127
12345